Patents by Inventor Kevin J. Friedman

Kevin J. Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mobile phone application for diabetes care with medical feature activation
    Patent number: 10003545
    Abstract: A method for activating a physician-prescribable feature of an application program executed on a mobile device is disclosed. The method includes receiving, by the application program, an activation code to activate a feature of the application program and one or more parameters associated with a prescription. The method includes transmitting, by the application program, the activation code to a server and receiving an authorization code from the server, where the authorization code indicates a validity of the activation code. The method includes activating, by the application program, the feature using the activation code, the activation being performed in response to the activation code being valid; configuring, by the application program, the activated feature using at least one of the one or more parameters associated with the prescription; and generating, using the activated feature, data based on the one or more parameters associated with the prescription.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: June 19, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Daniel Birtwhistle, Eric S. Carlsgaard, Michael L. Flis, Kevin J. Friedman, Hans P. Jensen, David B. Markisohn, Robert E. Reinke
  • MOBILE PHONE APPLICATION FOR DIABETES CARE WITH MEDICAL FEATURE ACTIVATION
    Publication number: 20140325065
    Abstract: A method for activating a physician-prescribable feature of an application program executed on a mobile device is disclosed. The method includes receiving, by the application program, an activation code to activate a feature of the application program and one or more parameters associated with a prescription. The method includes transmitting, by the application program, the activation code to a server and receiving an authorization code from the server, where the authorization code indicates a validity of the activation code. The method includes activating, by the application program, the feature using the activation code, the activation being performed in response to the activation code being valid; configuring, by the application program, the activated feature using at least one of the one or more parameters associated with the prescription; and generating, using the activated feature, data based on the one or more parameters associated with the prescription.
    Type: Application
    Filed: February 4, 2014
    Publication date: October 30, 2014
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Daniel Birtwhistle, Eric S. Carlsgaard, Michael L. Flis, Kevin J. Friedman, Hans P. Jensen, David B. Markisohn, Robert E. Reinke